封面
市場調查報告書
商品編碼
2020277

呼吸道管理設備市場規模、佔有率、成長及全球產業分析:按類型、應用和地區分類的洞察,2026-2034 年預測

Airway Management Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 126 Pages | 商品交期: 請詢問到貨日

價格

呼吸道管理設備市場的成長要素

全球呼吸道管理設備市場預計在2025年達到21.3億美元,2026年成長至22.3億美元,並在2034年達到32.5億美元,預測期內(2026-2034年)複合年成長率為4.85%。北美地區在2025年佔據市場主導地位,市佔率達47.1%,這主要得益於其高額的研發投入和先呼吸道管理技術的應用。

呼吸道管理設備,例如球囊面罩、氣管插管和喉鏡,在氣道阻塞患者的通氣和呼吸功能恢復中發揮著至關重要的作用。慢性阻塞性肺病(COPD)、癌症和慢性肺病等慢性疾病的盛行率不斷上升,顯著推動了對這些設備的需求。根據美國國家生物技術資訊中心(NCBI,2022)的數據顯示,全球40歲及以上人群中COPD的患病率約為10.1%;而美國肺臟協會(2020)報告稱,美國有1250萬成年人(佔總人口的5%)被診斷患有COPD、慢性支氣管炎或肺氣腫死亡,其中5121484人死亡。

慢性病盛行率的上升也導致全球急診和重症監護住院人數的增加。根據美國疾病管制與預防中心(CDC)2022年的數據,美國有1,620萬急診病患住院治療,其中230萬人需要重症監護。急診和住院人數的激增,加上外科手術和麻醉治療的增加,正在推動呼吸道管理設備的應用。

市場趨勢

隨著早產兒數量的增加,呼吸道管理設備的使用,尤其是在新生兒中的使用,正在不斷擴大。根據世界衛生組織(WHO)2023年的報告,全球約有1,340萬早產兒,佔所有新生兒的10%以上。在美國,根據美國疾病管制與預防中心(CDC)2022年的數據,每十個新生兒中就有一個是早產兒,且2020年至2021年間早產率上升了4%。早產兒常出現呼吸窘迫,因此對呼吸道管理的需求也隨之增加。美敦力公司的SonarMed系統等先進的兒童設備可即時監測氣管插管的位置,從而減少意外拔管等併發症,並改善治療效果。

市場成長要素

合資企業、Start-Ups以及主要產業參與者的研發投入進一步推動了這個市場的發展。美敦力、ICU Medical 和 Teleflex Incorporated 等公司正在擴大產能,並將創新醫療設備推向市場。例如,ICU Medical 於 2022 年收購 Smiths Medical,擴展了其在呼吸道管理和輸液設備產品系列。此外,LifeMech 的 A-VS 復甦設備於 2020 年獲得 FDA核准,為 COVID-19 疫情期間的緊急呼吸護理提供了支持。預計對這類技術先進設備的投資將推動新興市場的成長。

市場限制

儘管需求不斷成長,但醫療設備使用相關的併發症可能會限制其普及。插管呼吸道管理醫療設備有逆流、誤吸、血管壓迫、創傷和神經損傷等風險。根據美國國家生物技術資訊中心(NCBI,2021)統計,全球氣管切開術出血發生率為0.6%至5%;NCBI(2023)報告稱,與氣道裝置相關的心血管不穩定、低氧血症和心臟麻痹率分別為42.6%、9.3%和3.1%。兒童喉罩也可能導致軟組織損傷、嘔吐和氣道狹窄,因此其使用需謹慎考慮。

市場區隔

按類型:

  • 到2026年,聲門下呼吸道管理裝置將以55.46%的市場佔有率引領市場,這主要得益於慢性呼吸系統疾病盛行率的上升及其在重症監護室(ICU)中的應用。諸如內建攝影機的Ambu VivaSight 2雙腔支氣管導管等創新產品將提升臨床效率。
  • 另一方面,由於對一次性醫療器材的投資增加,因此聲門上器械的複合年成長率預計將更高。

用途:

  • 預計到 2026 年,麻醉將佔市場佔有率的 59.07%,到 2025 年,市場規模將達到 12.613 億美元,這主要得益於外科手術數量的增加。
  • 由於醫院就診量和創傷病例的增加,預計急診醫學將呈現更高的成長率。

按最終用戶分類:

  • 預計到 2026 年,醫院和門診手術中心 (ASC) 將佔市場佔有率的 78.56%。
  • 居家醫療正在擴展,尤其是在新冠肺炎疫情後,患有慢性呼吸系統疾病的老年人數量增加的情況下。

區域趨勢

  • 北美:預計到2025年將達到10.1億美元,到2026年將達到10.5億美元,主要受新產品發布和合作關係的推動。美國市場:8.4億美元(2026年)。
  • 歐洲:6.7億美元(2025年),7.1億美元(2026年),年複合成長率5.6%。英國:5000萬美元,德國:1.9億美元(2026年)。
  • 亞太地區:2025 年為 3 億美元,2026 年為 3.1 億美元,在中國和印度的推動下,複合年成長率較高。
  • 拉丁美洲:1億美元(2025-2026年)。
  • 中東和非洲:5000萬美元至6000萬美元(2025-2026年)。

主要企業及趨勢

主要企業包括美敦力(愛爾蘭)、泰利福醫療(美國)、卡爾史托斯(德國)、ICU Medical(美國)、康維泰克(英國)、安佈公司(丹麥)和英特斯卡公司(英國)。近期發展如下:

  • 2023年6月:Morf Nazar面具發表。
  • 2022 年 1 月:Intersurgical Ltd 收購 Pulmodyne,擴大了在企業發展。
  • 2021年5月:Teleflex收購非侵入性通氣產品。
  • 2021年3月:康維泰克收購Cure Medical。

目錄

第1章:引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章:主要考慮因素

  • 2025/2025年主要國家及地區慢性阻塞性肺病(COPD)盛行率
  • 主要國家氣喘盛行率,2025/2025
  • 新產品發布:按主要企業分類
  • 產業主要趨勢:主要企業的合併、聯盟和收購。
  • 新冠疫情的影響:全球呼吸道管理設備市場

第5章:全球呼吸道管理設備市場分析、洞察與預測(2021-2034年)

  • 市場分析、洞察與預測:按類型
    • 聲門下呼吸道管理裝置
      • 氣切管
      • 氣管插管(ETTS)
    • 聲門上呼吸道管理裝置
      • 口嚥氣道(OPAS)
      • 喉罩方形路(LMAS)
      • 鼻嚥氣道
    • 喉鏡
    • 其他
  • 市場分析、洞察與預測:按應用領域分類
    • 麻醉
    • 緊急醫療護理
    • 其他
  • 市場分析、洞察與預測:按最終用戶分類
    • 醫院和門診手術中心(ASC)
    • 居家醫療
    • 其他
  • 市場分析、洞察與預測:按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章:北美呼吸道管理設備市場分析、洞察與預測(2021-2034年)

  • 國家
    • 美國
    • 加拿大

第7章:歐洲呼吸道管理設備市場分析、洞察與預測(2021-2034年)

  • 國家
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 英國
    • 其他歐洲國家

第8章:亞太地區呼吸道管理設備市場分析、洞察與預測(2021-2034年)

  • 國家
    • 中國
    • 印度
    • 東南亞
    • 日本
    • 澳洲
    • 其他亞太國家

第9章:拉丁美洲呼吸道管理設備市場分析、洞察與預測(2021-2034年)

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章:中東和非洲呼吸道管理設備市場分析、洞察與預測(2021-2034年)

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析(2025 年)
  • 公司簡介
    • Medtronic
    • Teleflex Incorporated
    • KARL STORZ SE & Co. KG
    • ICU Medical
    • Convatec Inc.
    • Ambu A/S
    • Intersurgical Ltd
    • VBM Medizintechnik GmbH
    • VYAIRE MEDICAL, INC.
    • Flexicare(Group)Limited
Product Code: FBI107396

Growth Factors of airway management devices Market

The global airway management devices market was valued at USD 2.13 billion in 2025 and is projected to grow to USD 2.23 billion in 2026, reaching USD 3.25 billion by 2034, reflecting a CAGR of 4.85% during the forecast period (2026-2034). North America dominated the market with a 47.1% share in 2025, driven by high R&D investments and the launch of advanced airway management technologies.

Airway management devices, including bag-valve masks, endotracheal tubes, and laryngoscopes, play a critical role in providing ventilation and restoring breathing in patients with airway obstruction. The rising prevalence of chronic conditions such as COPD, cancer, and chronic lung diseases has significantly contributed to the demand for these devices. According to the National Center for Biotechnology Information (NCBI, 2022), the global prevalence of COPD among people aged 40 and above is around 10.1%, while the American Lung Association (2020) reported that 12.5 million U.S. adults (5% of the population) were diagnosed with COPD, chronic bronchitis, or emphysema, with 148,512 deaths recorded due to COPD.

The increase in chronic disease prevalence has also amplified emergency and intensive care admissions globally. In the U.S., CDC data (2022) shows 16.2 million emergency department visits resulted in hospital admissions, with 2.3 million requiring critical care. This surge in emergency and inpatient care, coupled with rising surgical procedures and anesthetic interventions, has driven the adoption of airway management devices.

Market Trends

The adoption of airway management devices is particularly increasing among neonates, due to the rise in premature births. The WHO (2023) reported approximately 13.4 million premature births worldwide in 2020, representing more than 10% of all births. In the U.S., CDC (2022) data indicates 1 in 10 births is preterm, with a 4% increase in preterm birth rate from 2020 to 2021. Premature infants frequently experience breathing disorders, increasing the need for airway management. Advanced pediatric devices, such as Medtronic's SonarMed system, allow real-time monitoring of endotracheal tube positioning, reducing complications like unplanned extubations and improving outcomes.

Market Growth Factors

The market is further bolstered by joint ventures, start-ups, and R&D investments by key industry players. Companies like Medtronic, ICU Medical, and Teleflex Incorporated are expanding production capabilities and launching innovative devices. For example, ICU Medical's acquisition of Smiths Medical in 2022 expanded its portfolio in airway management and infusion devices, while LifeMech's A-VS resuscitator received FDA approval in 2020, supporting emergency respiratory care during COVID-19. These investments in technologically advanced devices are anticipated to propel market growth across emerging nations.

Market Restraints

Despite growing demand, complications associated with device use can limit adoption. Intubation and airway devices carry risks such as regurgitation, aspiration, vascular compression, trauma, and nerve injury. According to NCBI (2021), tracheostomy bleeding occurs in 0.6-5% of cases globally, and NCBI (2023) reports cardiovascular instability, hypoxemia, and cardiac arrest rates of 42.6%, 9.3%, and 3.1%, respectively, linked to airway devices. Pediatric laryngeal masks may also cause soft-tissue trauma, vomiting, and airway restriction, highlighting the need for cautious usage.

Market Segmentation

By Type:

  • Infraglottic airway management devices led the market with 55.46% share in 2026, driven by chronic respiratory disease prevalence and ICU usage. Innovations such as Ambu VivaSight 2 DLT with a built-in camera enhance clinical efficiency.
  • Supraglottic devices are projected to grow at a higher CAGR due to rising investments in single-use devices.

By Application:

  • Anesthesia dominates with 59.07% share in 2026, generating USD 1,261.3 million in 2025, fueled by increasing surgical procedures.
  • Emergency medicine is projected to register higher growth due to rising hospital visits and trauma incidents.

By End-User:

  • Hospitals & ASCs accounted for 78.56% share in 2026.
  • Homecare is expanding due to increasing geriatric populations with chronic respiratory conditions, particularly post-COVID-19.

Regional Insights

  • North America: USD 1.01 billion (2025), projected USD 1.05 billion (2026), driven by new device launches and collaborations. U.S. market: USD 0.84 billion (2026).
  • Europe: USD 0.67 billion (2025), USD 0.71 billion (2026), CAGR 5.6%. UK: USD 0.05 billion; Germany: USD 0.19 billion (2026).
  • Asia Pacific: USD 0.3 billion (2025), USD 0.31 billion (2026), strong CAGR, led by China and India.
  • Latin America: USD 0.1 billion (2025-2026).
  • Middle East & Africa: USD 0.05-0.06 billion (2025-2026).

Key Companies & Developments

Prominent players include Medtronic (Ireland), Teleflex Incorporated (U.S.), KARL STORZ (Germany), ICU Medical (U.S.), Convatec (U.K.), Ambu A/S (Denmark), and Intersurgical Ltd (U.K.). Recent developments include:

  • June 2023: Morf Nasal Mask launch.
  • Jan 2022: Intersurgical's acquisition of Pulmodyne, expanding U.S. and global reach.
  • May 2021: Teleflex acquisition of non-invasive ventilation products.
  • March 2021: Convatec acquisition of Cure Medical.

Conclusion

The global airway management devices market is poised for steady growth, driven by rising chronic respiratory disorders, increasing surgical and emergency procedures, technological advancements, and expanding applications in neonatal care. While complications associated with device usage remain a restraint, strategic investments, product innovations, and regional expansion efforts by key players are expected to propel the market to USD 3.25 billion by 2034.

Segmentation By Type

  • Infraglottic Airway Management Devices
    • Endotracheal Tubes
    • Tracheostomy Tubes
  • Supraglottic Airway Management Devices
    • Oropharyngeal Airways (OPAS)
    • Laryngeal Mask Airways (LMAS)
    • Nasopharyngeal Airways
  • Laryngoscopes
  • Others

By Application

  • Anesthesia
  • Emergency Medicine
  • Others

By End User

  • Hospitals & ASCs
  • Home care
  • Others

By Region

  • North America (By Type, Application, End User and Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Type, By Application, End User and Country/Sub-Region)
    • Germany (By Application)
    • France (By Application)
    • U.K. (By Application)
    • Spain (By Application)
    • Italy (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Type, Application, End User and Country/Sub-Region)
    • China (By Application)
    • India (By Application)
    • Southeast Asia (By Application)
    • Japan (By Application)
    • Australia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Type, Application, End User and Country/Sub-Region)
    • Mexico (By Application)
    • Brazil (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Type, End User, and Country/Sub-Region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of MEA (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Chronic Obstructive Pulmonary Disease, By Key Countries/Sub-Region, 2025/2025
  • 4.2. Prevalence of Asthma, By Key Countries, 2025/2025
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments: Mergers, Partnerships, & Acquisitions, By Key Players
  • 4.5. Impact of COVID-19 on Global Airway Management Devices Market

5. Global Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Infraglottic Airway Management Devices
      • 5.1.1.1. Tracheostomy Tubes
      • 5.1.1.2. Endotracheal Tubes (ETTS)
    • 5.1.2. Supraglottic Airway Management Devices
      • 5.1.2.1. Oropharyngeal Airways (OPAS)
      • 5.1.2.2. Laryngeal Mask Airways (LMAS)
      • 5.1.2.3. Nasopharyngeal Airways
    • 5.1.3. Laryngoscopes
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Anesthesia
    • 5.2.2. Emergency Medicine
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Home Care
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Infraglottic Airway Management Devices
      • 6.1.1.1. Tracheostomy Tubes
      • 6.1.1.2. Endotracheal Tubes (ETTS)
    • 6.1.2. Supraglottic Airway Management Devices
      • 6.1.2.1. Oropharyngeal Airways (OPAS)
      • 6.1.2.2. Laryngeal Mask Airways (LMAS)
      • 6.1.2.3. Nasopharyngeal Airways
    • 6.1.3. Laryngoscopes
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Anesthesia
    • 6.2.2. Emergency Medicine
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Home Care
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Infraglottic Airway Management Devices
      • 7.1.1.1. Tracheostomy Tubes
      • 7.1.1.2. Endotracheal Tubes (ETTS)
    • 7.1.2. Supraglottic Airway Management Devices
      • 7.1.2.1. Oropharyngeal Airways (OPAS)
      • 7.1.2.2. Laryngeal Mask Airways (LMAS)
      • 7.1.2.3. Nasopharyngeal Airways
    • 7.1.3. Laryngoscopes
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Anesthesia
    • 7.2.2. Emergency Medicine
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Home Care
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
      • 7.4.1.1. By Application
    • 7.4.2. Spain
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Italy
      • 7.4.4.1. By Application
    • 7.4.5. U.K.
      • 7.4.5.1. By Application
    • 7.4.6. Rest of Europe
      • 7.4.6.1. By Application

8. Asia Pacific Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Infraglottic Airway Management Devices
      • 8.1.1.1. Tracheostomy Tubes
      • 8.1.1.2. Endotracheal Tubes (ETTS)
    • 8.1.2. Supraglottic Airway Management Devices
      • 8.1.2.1. Oropharyngeal Airways (OPAS)
      • 8.1.2.2. Laryngeal Mask Airways (LMAS)
      • 8.1.2.3. Nasopharyngeal Airways
    • 8.1.3. Laryngoscopes
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Anesthesia
    • 8.2.2. Emergency Medicine
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Home Care
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
      • 8.4.1.1. By Application
    • 8.4.2. India
      • 8.4.2.1. By Application
    • 8.4.3. Southeast Asia
      • 8.4.3.1. By Application
    • 8.4.4. Japan
      • 8.4.4.1. By Application
    • 8.4.5. Australia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Infraglottic Airway Management Devices
      • 9.1.1.1. Tracheostomy Tubes
      • 9.1.1.2. Endotracheal Tubes (ETTS)
    • 9.1.2. Supraglottic Airway Management Devices
      • 9.1.2.1. Oropharyngeal Airways (OPAS)
      • 9.1.2.2. Laryngeal Mask Airways (LMAS)
      • 9.1.2.3. Nasopharyngeal Airways
    • 9.1.3. Laryngoscopes
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Anesthesia
    • 9.2.2. Emergency Medicine
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Home Care
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Infraglottic Airway Management Devices
      • 10.1.1.1. Tracheostomy Tubes
      • 10.1.1.2. Endotracheal Tubes (ETTS)
    • 10.1.2. Supraglottic Airway Management Devices
      • 10.1.2.1. Oropharyngeal Airways (OPAS)
      • 10.1.2.2. Laryngeal Mask Airways (LMAS)
      • 10.1.2.3. Nasopharyngeal Airways
    • 10.1.3. Laryngoscopes
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Anesthesia
    • 10.2.2. Emergency Medicine
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Home Care
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Teleflex Incorporated
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. KARL STORZ SE & Co. KG
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. ICU Medical
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Convatec Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Ambu A/S
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Intersurgical Ltd
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. VBM Medizintechnik GmbH
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. VYAIRE MEDICAL, INC.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Flexicare (Group) Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 02: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices Type, 2021-2034
  • Table 03: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices Type, 2021-2034
  • Table 04: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 05: Global Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 06: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 07: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 08: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 09: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 10: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: North America Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: U.S. Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Canada Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 15: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 16: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 17: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 18: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Germany Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Spain Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: France Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Italy Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 25: U.K. Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 26: Rest of Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 28: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 29: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 30: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 33: China Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: India Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 35: Southeast Asia Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 36: Japan Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 37: Australia Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Rest of Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 39: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 40: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 42: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 43: Brazil Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 44: Mexico Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 45: Rest of Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 46: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 47: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 48: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 49: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 50: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 51: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 52: GCC Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 53: South Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 54: Rest of Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 01: Global Airway Management Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Airway Management Devices Market Value Share (%), By Type, 2025 & 2034
  • Figure 03: Global Airway Management Devices Market Value Share (%), By Application, 2025 & 2034
  • Figure 04: Global Airway Management Devices Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Airway Management Devices Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 07: North America Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 08: North America Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 09: North America Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 10: North America Airway Management Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 12: North America Airway Management Devices Market Value (USD billion), by Country, 2025 & 2034
  • Figure 13: North America Airway Management Devices Market Value Share (%), by Country, 2025
  • Figure 14: Europe Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 16: Europe Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 18: Europe Airway Management devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 20: Europe Airway Management Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe Airway Management Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 22: Asia Pacific Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Airway Management Devices Market Value Share (%),
  • Figure 24: Asia Pacific Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Airway Management devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Airway Management Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Airway Management Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 30: Latin America Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Airway Management Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Airway Management Devices Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034
  • Figure 37: Latin America Airway Management Devices Market Value Share (%), by Country/ Sub-Region, 2025
  • Figure 38: Middle East & Africa Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Airway Management Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Airway Management Devices Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Airway Management Devices Market Value Share (%), by Country/ Sub-Region, 2025
  • Figure 46: Global Airway Management Devices Market Share Analysis (%), By Company, 2025